Last reviewed · How we verify

NCT06758440

Effectiveness of Hydroxyapatite Reinforced Chitosan Hydrogel in Modulation of Osseointegration

Completed NA Last updated 3 January 2025
What this trial tests

NA trial testing chitosan in Osseointegration Failure of Dental Implant in 20 participants. Completed in 30 March 2024.

Timeline
28 March 2023
Primary endpoint
20 March 2024
30 March 2024

Quick facts

Lead sponsorMinia University
PhaseNA
StatusCompleted
Study typeINTERVENTIONAL
Allocationrandomized
Designparallel
Maskingdouble
Primary purposetreatment
Enrollment20
Start date28 March 2023
Primary completion20 March 2024
Estimated completion30 March 2024
Sites1 location across Egypt

Drugs / interventions tested

Conditions studied

Sponsor

Minia University

Who can join

Adults 20 to 50, any sex, with Osseointegration Failure of Dental Implant. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

Dental implant treatments have now become indispensable in clinical dental practice. The survival rate exceeds 90%; Modern oral implantology uses different devices, in terms of size, shape, length, thickness and composition, from pure titanium to titanium-aluminum-vanadium alloys, due to their biocompatibility and high corrosion resistance

Publications & conference data

1 peer-reviewed publication reference this trial (live from Europe PMC):

  1. Recent Advances in Polysaccharide-Based Hydrogels for Tumor Immunotherapy.
    Zhou Y, Chen K, Cheng H, Zhang S. · · 2025 · cited 4× · PMID 40136857 · DOI 10.3390/gels11030152

Verify or expand the search:

Other recruiting trials for Osseointegration Failure of Dental Implant

Currently open trials in the same condition.

Other Minia University trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT06758440.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing